The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourFlu Hospitalization Rate Week 21, 2026?
Flu Hospitalization Rate Week 21, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$5,474 Vol.
$5,474 Vol.
5 juin 2026
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$5,474 Vol.
$5,474 Vol.
5 juin 2026
<80
$647 Vol.
No
80–85
$360 Vol.
No
85–90
$1,193 Vol.
Yes
90–95
$1,382 Vol.
No
95–100
$928 Vol.
No
100+
$964 Vol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Marché ouvert : Jun 1, 2026, 12:42 PM ET
Volume
$5,474Date de fin
5 juin 2026Marché ouvert
Jun 1, 2026, 12:42 PM ETSource de résolution
https://www.cdc.gov/fluview/index.htmlResolver
0x69c47De9D...Résultat proposé: No
Aucune contestation
Résultat final: No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volume
$5,474Date de fin
5 juin 2026Marché ouvert
Jun 1, 2026, 12:42 PM ETSource de résolution
https://www.cdc.gov/fluview/index.htmlResolver
0x69c47De9D...Résultat proposé: No
Aucune contestation
Résultat final: No
The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes